XNAS: ERNA
Eterna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the ...
Read More
3.96
0.13
(3.39%)
13,495
XNAS Volume
High vol. this week
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Eterna Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..